Archive for March, 2010

HCR: Key contacts, grassroots supporters come through

Wednesday, March 31st, 2010

In a recent blog, I thanked our Government Affairs staff and those of other pharmacy organizations for sticking together to achieve success in the health care reform process. In addition, lots of others deserve thanks and recognition for their efforts during this important time in pharmacy history.

Heroes this past year include our members who served as volunteers and advocates on our Government Affairs Committee and Key Contact Network, or those who were active in our grassroots-lobbying initiatives. Every pharmacist in America owes a debt of gratitude to their colleagues who cared enough to contact their Members of Congress.

Let’s keep up the momentum and the unity! We still have a long way to go, but we’re off to a great start on redefining pharmacy’s future.

The Dems did it! Now it’s our turn

Tuesday, March 23rd, 2010

The health care reform (HCR) bill signed this morning by President Obama includes provisions to ensure patient access to pharmacists’ medication therapy management (MTM) services, medications, and a viable pharmacy infrastructure. These critical services reduce the toll of inappropriate medication use, including nonadherence, and improve the quality of our nation’s health care system.

APhA strongly supported the bill’s inclusion of provisions to address our nation’s medication-use crisis. This is an opportunity for us to deliver as the medication experts on the health care team. We opened the door for the recognition of pharmacists’ services. Now we need to continue that work with regulators and our colleague organizations to ensure that patients have the tools that they need to use their medications safely and effectively.

The opportunity is there—grasp it!

HCR passage imminent

Sunday, March 21st, 2010

At this writing, the passage of health care reform legislation appears imminent. This morning, the Democrats announced they now have the necessary 216 votes.

Like many comprehensive proposals, this bill may need to be “tweaked” in years to come as we see the benefits roll out (which in some cases will happen several years from now). While your politics may differ from the current path on the broader aspects of the legislation, this effort was, at least by my account, unprecedented. It includes some major advances for pharmacy.

Intact in the final bill are pharmacy’s provisions. We helped to shape those elements, and all of pharmacy advocated their passage. Perhaps the MTM grant programs could have been larger, but what we have is a good move in the right direction.

We will have years of work ahead of us in the regulatory process to assure that our patients get the full benefit of our services. And pharmacists will have to step up and deliver. But the profession’s years of work to promote patient care services together with safe and accurate dispensing production may be paying off.

Congrats to our APhA Government Affairs team and our HCR Task Force, not only for their incredible hard work, but for their productivity, effectiveness, and excellent communications with our membership. Congrats too to all of the other pharmacy association government affairs teams. It has been and will continue to be a pleasure working with all of you.

House Democratic leaders expect the vote on HCR to occur between 6 p.m. and midnight this evening. Watch pharmacist.com for news and updates as the vote occurs.

Watch out for diverted drugs!

Thursday, March 18th, 2010

On a gram-for-gram basis, many drugs are now more expensive than gold. That fact is not lost on the criminals among us, as reflected in a pharmacist.com news story detailing several recent heists of medications and nutritional products. But remember one thing: These thieves wouldn’t have risked doing this if there weren’t a brisk black market in the United States for the sale of diverted or stolen pharmaceuticals.

I believe pharmacists in this country take supply-chain integrity for granted. I say this with the perspective of someone who spent almost 8 years doing supply-chain audits and chasing diverted drugs all over the world. My opinion doesn’t come just from my own experiences (which focused largely on the mainstream distribution system in the United States, where major improvements in security have occurred) but also from conversations and meetings with many industry security professionals who are faced with protecting their companies’ products. These folks are challenged every day in this country and around the world. 

These recent high-profile thefts should serve as a reminder to all pharmacists to pay attention to where you purchase your pharmaceuticals. Know your distributor and ask questions about their practices. Do not respond to faxes offering deals you know are too good to be true. These thieves will find someone to buy their take—make sure it isn’t one of your patients who ends up with these diverted drugs! If you are not careful, this could happen to you.

In addition, be sure to warn your patients about the dangers of buying drugs from the Internet. Most diverted drugs will find their way to consumers through this channel. The National Association of Boards of Pharmacy tries to warn Internet consumers they should use only known sites that are verified through NABP’s VIPPS program. But with all the noise consumers hear, it is a difficult message to convey. Be sure your patients hear it!

APhA2010: If you weren’t here, you missed a valuable opportunity!

Wednesday, March 17th, 2010

Nearly 7,000 of my closest friends just left Washington. Those who experienced APhA2010 went home re-energized and enthusiastic about our profession! Teachers came to learn, and many learners found themselves teaching. Our job as your association is to find the best and the brightest and to provide a venue for those people to share their knowledge with other professionals who have figured out that the need for lifelong learning is one of the major planks in a fulfilling life.

We have the content of our educational programs audited for content and quality. Our auditors told us this year’s body of work was the best they had ever seen. But there’s more in this embarrasment of riches we call our Annual Meeting.

We had politics, with a keynote presentation by Mark McClellan, former head at FDA and CMS. At the Political Leadership Breakfast, more than 550 pharmacists and student pharmacists gathered at 7 am to hear from senior staff of the Senate Finance Committee.

We also highlighted the achievements and contributions of dozens of award winners, topped off by a beautiful Remington Honor Medalist speech by Mary Ann Koda-Kimble of the University of California, San Francisco. I was especially moved by her inspirational words about the importance of mentorship and our ability to rise above adversity.

As a follow-up to last year’s presentation by Francis Collins, now NIH head, we also heard from geneticist Alan Guttmacher. He shared his thoughts with us about the present and future opportunities for pharmacists to be the professionals to help consumers understand the burgeoning information about pharmacogenomics and the impact our genetic makeup is having on drug therapy.

Our House of Delegates took a significant stand against the sale of tobacco in pharmacies and considered how we should view any community pharmacy accreditation process. As my predecessor John Gans likes to say, we had “red meat” in the House this year!

I also was moved by the orderly and exemplary transition of leadership that occurs each year. Former President Tim Tucker ended his 10-year run on the Board of Trustees, and Ed Hamilton completed his term as President. I can’t say enough about these two gentlemen and what their friendship and guidance have meant to me this year. Harold Godwin took the helm as President for 2010–11. His background and work with students and residents shows in his approach to leadership. He is truly a collaborator, and I look forward to a great year with him as my boss.

If you are reading this, you care about pharmacy. If you care about pharmacy, make plans now to attend next year’s meeting in Seattle. You have my personal guarantee that you won’t be disappointed. If you are on the fence, just talk to someone who comes regularly, like my friends Sami and Ilan from Israel who travel thousands of miles every year to attend our meetings and go home with their brains once again overflowing with ideas and opportunities.

Gotta go. It’s time to start planning next year’s meeting!

APhA2010: One inch!

Friday, March 12th, 2010

By 8:30 this Friday morning, one inch of the APhA Annual Meeting was complete! I sat in the staff office at the convention center in Washington, DC, and thinned out the binder that contains schedules, scripts and “continuities,” contact information, presentations, and background information. Hundreds of functions occur in what to an outsider may look like a cacophony of activity, but in reality is a well-choreographed set of events whose planning started years ago.

For me, the first on-site meetings began on Wednesday. By this morning, I was able to take an inch of paper out of my binder, which serves as my “bible” through the roughly 7 days of meetings.

Our Board of Trustees meeting is complete, and our work with state associations is well under way. It is so energizing to associate with so many motivated and innovative pharmacists. While we’re beating last year’s attendance numbers, I wish we could get every pharmacist in America to attend. We could cross-pollinate best practices so much faster if more pharmacists congregated, engaged, and networked in forums like this one.

For APhA2010, the train has left the station. All the planning is done, and now we execute! In what will seem like a blur, the meeting will be over. We will review everything that happened so that APhA2011 can be our best Annual Meeting ever!

If you are reading this, and you are not here in Washington, make your plans now to be in Seattle on March 25–28, 2011. And make sure you attend your state association meeting this year! The wealth of information and networking opportunities available at pharmacy meetings are a great way to recharge your professional batteries and stay current in your practice. I’ll see you at many state association meetings this year and APhA2011 next March!

PS You can follow all the action at APhA2010 on Twitter and Facebook. Follow our Twitter feed or find us on Facebook.

Help your patients with Fox termination

Wednesday, March 10th, 2010

I received a call yesterday from Chris Worral and Jeff Kelman of CMS, one relating news that affects the provision of Part D prescription drugs to more than 123,000 Medicare beneficiaries. Pharmacists, as front-line practitioners, will be instrumental in helping patients understand the situation and what is happening to their medicines.

CMS terminated its contract with a prescription drug plan (PDP), Fox Insurance Company, which was providing Part D benefits to patients in 21 states. The action took effect immediately. All patients enrolled with Fox will temporarily receive their medications through LI Net/Humana, a program run by Medicare and administered by Humana. More details about this action are available in a news article posted last night on pharmacist.com.

Dr. Kelman stressed to me that all drugs will be reimbursed and that patients should not walk out of pharmacies empty handed. Implicit in that statement is that CMS will back the pharmacies if questions arose.

I encourage all pharmacists who encounter patients affected by this action to take a moment to explain to them that medicines are being covered and that patients have the option of choosing a new PDP between now and May 1. If beneficiaries do not choose a new PDP, one will be assigned for them by CMS, so it is important they proactively choose a plan that will best meet their needs.

Meetings about meetings!

Thursday, March 4th, 2010

As the House of Representatives “Rangels” about its leadership, APhA has been meeting about meetings!

Earlier this week, our staff conducted our final preconference planning meeting (“precon”) for the Annual Meeting coming up on March 12–15 here in Washington. Our staff is really pumped, and it was fun to listen to the banter as people from our various departments very professionally—but not too seriously—slugged through the incredible detail that makes one of these meetings a success.

We’re certainly buoyed by the response of our membership—we’ve already exceeded last year’s Annual Meeting registration numbers. Our staff is also excited about the quality of our speakers and the meeting content. Here’s a tip of the hat to a great staff!

I’m also very proud of our Board of Trustees. They volunteer hundreds of hours to provide leadership and perspective to us. Many of them have recruited dozens of student pharmacists and new practitioners to attend the political leadership breakfast on Monday morning. These events have the potential to make an indelible mark on impressionable pharmacists in the early stages of their careers. This mentorship is laudable, and not bad for supporting our advocacy agenda either!

So, while things are shaping up for our meeting, we’re still very unsure about what Congress will do with health care reform. Charlie Rangel (D–NY), under scrutiny for ethics violations, is stepping aside from his powerful leadership post on the House Ways and Means Committee. Lawmakers are debating the pros and cons of reconciliation as a legislative maneuver to pass a majority-supported HCR bill. President Obama is supporting that approach—even giving Congress a 2-week timeframe in which he’d like to see movement. Senate Republicans say we should start over, but that’s not going to happen.

Meanwhile, as far as we can tell, all of the MTM provisions we’ve fought so hard for this past year are still in the bills under consideration. Stay tuned. This ain’t over yet.